menu
    • menu

    Company profile for Alchem International Private Ltd

    Key Product, Service and Excipients-PSE
    News
    Prof. Dr. Serhat Ünal Tells: Things to Consider in the Influenza & COVID Spiral

    17 Dec 2022

    // WINALLY

    Sales Focus Expands Sales Outsourcing Services into the Healthcare Industry

    01 Nov 2022

    // PR NEWSWIRE

    AlChem Life USA and Stevenson Advocacy LLC donate $1.35 million worth

    14 Oct 2021

    // PHILLYVOICE

    DATA COMPILATION
    #PharmaFlow

    Alchem

    Contact Supplier

    Website

    CPhI WW Frankfurt

    Booth #11.0C48

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/rZFcvrT4uSc

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Products KEY SERVICES

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Related CompaniesRelated Companies

    About

    Alchem International, established in 1935, is a pioneer in phytochemicals, providing plant-derived active pharmaceutical ingredients to the pharmaceutical, cosmetic and nutraceutical industries. With over 75 years of experience, Alchem has established a global presence, selling its products in more than 35 countries. Alchem has three manufacturing sites spread across 62 acres in India and four international divisions with offices in India, Europe, Hong Kong and the US. Alchem has two divisions – Phytoceuticals and EpiQue – that provide healthcare and cosmetic products to the Indian market and employs over 1,000 people worldwide.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alchem International Private Ltdindia-flag Flag
    Country
    Country
    India
    Address
    Address
    201, Empire Plaza, Mehrauli - Gurgaon Road, Sultanpur, New Delhi-110 030
    Telephone
    Telephone
    +91 1126809882
    Client Email
    Email
    geeta@alcheminternational.com
    Client Website
    Website
    http://www.alcheminternational.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alchem-international-pvt-ltd/
    youtube
    YouTube
    https://www.youtube.com/@AlchemLifeIndia/videos
    Twitter
    Twitter
    Contact Info
    Others

    Email ID:

    contact@alcheminternational.com

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI North America

    Not Confirmed

    envelop Contact Supplier

    CPhI North America

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    INTERVIEW #SpeakPharma

    read-more
    read-more
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experienceAddressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise. HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 52

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    01 Jan 2022
    Share info Share

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/alchem-international-private-ltd-party-content-75699.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/alchem-international-private-ltd-party-content-1604146223.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2017

    read-more

      https://www.pharmacompass.com/pdf/party/content/alchem-international-private-ltd-party-content-1633932351.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    DATA COMPILATION #PharmaFlow

    read-more
    read-more
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Every year, the US Food and Drug Administration (FDA) publishes the user fee amounts it will collect from manufacturers of pharmaceuticals, generic drugs, biosimilars and medical devices in the coming financial year. The fee for fiscal year 2025 under the Generic Drug User Fee Act (GDUFA) was published on July 31, 2024.The GDUFA, established in 2012, authorizes FDA to assess and collect fees from drug manufacturers to expedite the delivery of safe, high-quality, and affordable generic drugs to the American public.The FDA’s facility payments list under GDUFA reveals that as of November 14, 2024, 1,397 facilities had paid their registration fees for financial year 2025. Of these facilities, 707 or 50.6 percent are active pharmaceutical ingredients (API) facilities, 405 or 29 percent are finished dosage forms (FDF) facilities, 69 (4.9 percent) are facilities that produce both APIs and FDFs, and 216 (15.5 percent) are contract manufacturing services (CMO) sites.Teva Pharmaceuticals, with 29 facility registrations, led the list of companies, followed by Aurobindo Pharma, Sun Pharma, and Dr. Reddy's Laboratories. Fiscal year Facility Registrations 2016 1,425 2017 1,442 2018 1,269 2019 1,286 2020 1,300 2021 1,340 2022 1,385 2023 1,394 2024 1,447 2025 1,397  Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available)India continues to lead with 396 facilities, US and China follow India maintains its dominance in total facility registrations with the FDA, registering 396 facilities for FY2025. This includes 214 API facilities, 135 FDF facilities, 21 facilities engaged in both API and FDF activities, and 26 CMO facilities.The United States holds the second position with 328 facilities, while China strengthened its third position with 197 facilities.With 214 API facilities, India continues to have the largest share of API manufacturing sites, outmatching the combined total of China (128) and the US (83), which together account for 211 facilities. Among European manufacturers, Italy leads with 59 API manufacturing sites, followed by Spain (30) and Germany (25).The US has maintained its lead in FDF facilities with 143 sites, followed closely by India with 135 sites and China with 45 sites. Country API FDF Both CMO Total India 214 135 21 26 396 US 83 143 13 89 328 China 128 45 12 12 197 Italy 59 3 2 19 83 Germany 25 4 1 15 45 Spain 30 9 1 4 44 Canada 7 17   13 37 Taiwan 9 6 5 4 24 Switzerland 15 4   4 23 France 16     6 22 Japan 18   1   19 United Kingdom 12 1   2 15 Mexico 9 1   1 11 Ireland 5 5   1 11   Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) GDUFA III user fee rates increase across categories for FY25The GDUFA, which was reauthorized on September 30, 2022 (as GDUFA III), continues with provisions that will last until September 30, 2027. In July 2024, the FDA published updated user fee rates for FY2025.The facility fees have seen increases across all categories. API facility fees increased by 3 percent for domestic sites (to US$ 41,580) and 2 percent for foreign sites (to US$ 56,580). FDF facility fees rose by 5 percent for both domestic (to US$ 231,952) and foreign sites (to US$ 246,952). CMO facility fees increased by 5 percent for domestic sites (to US$ 55,668) and 4 percent for foreign sites (to US$ 70,668).Additionally, the fee for large-, medium- and small-sized drug applicants has increased by over 9 percent, compared to the 7 percent increase seen in 2023. Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) China leads new facility registrations as FDA records 41 new units in FY25Out of the total 1,397 facilities registered for FY2025, 41 were new registrations (going by Facility FDA Establishment Identifier numbers). China led the way with 13 new facilities, followed closely by India with 11 new facilities, while the US secured the third position with eight new facilities.The new registrations included 15 API facilities, 13 CMO facilities, 12 FDF facilities, and one facility engaged in both API and FDF activities. Chinese companies dominated the new FDF registrations with six facilities: Chengdu Shuode Pharma, Chengdu Suncadia Medicine, Cipla (Jiangsu), GE Healthcare (Shanghai), Luoxin Aurovitas Pharma (Chengdu), and Zhejiang Xianju Pharma.India added two new FDF facilities through Eugia Steriles and Zydus Pharma. Malaysia registered two FDF facilities through Novugen Pharma and Novugen Oncology, while Turkey’s Insud Pharma subsidiary Exeltis and US’ RK Pharma registered one FDF facility each.The 13 new CMO facilities included, Acme Generics, Emcure, Esjay Pharma, Fordoz Pharma, Fourrts Laboratories, Laboratoires KABS, PharmaMax, Quality Packaging Specialists International, Ritsa Pharma, Shanghai Aucyun Pharma, Sichuan Huiyu Pharma, Taejoon Pharm, and Tubilux Pharma.In the API category, the 15 new registrations included Acharya Chemicals, Hainan Poly Pharma, CBL Patras, EUROAPI, Hybio Pharma, Medilux Laboratories, Metrochem API, Purolite, Chengdu Easton Biopharma, Sionc Pharma, Smithfield Bioscience, Xttrium Laboratories, Zhejiang Hengkang Pharma, Moehs Iberica and Shilpa Pharma. Armstrong Pharmaceuticals registered the sole facility for both APIs and FDFs.So far, 92 facilities have not renewed their registration. Among these was a facility owned by Sandoz subsidiary Eon Labs in Wilson, North Carolina (US), which is permanently closed. In fact, the geographical distribution of non-renewals shows that 30 facilities were from the US, while India and China accounted for 14 and nine non-renewals respectively. Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) Our viewThe FY 2025 GDUFA facility registration data indicates a continued strong presence of Indian manufacturers in the US generic drug market, particularly in API production. However, China's leadership in new facility registrations, especially in FDF manufacturing, suggests that the global generic drug supply chain landscape may evolve considerably in the coming years. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 13300

    https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities

    #PharmaFlow by PHARMACOMPASS
    21 Nov 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Prof. Dr. Serhat Ünal Tells: Things to Consider in the Influenza & COVID Spiral
    Prof. Dr. Serhat Ünal Tells: Things to Consider in the Influenza & COVID Spiral

    17 Dec 2022

    // WINALLY

    https://www.pharmacompass.com/pdf/news/prof-dr-serhat-nal-tells-things-to-consider-in-the-influenza-covid-spiral-55169.pdf

    WINALLY
    17 Dec 2022
    Share Share
    Sales Focus Expands Sales Outsourcing Services into the Healthcare Industry
    Sales Focus Expands Sales Outsourcing Services into the Healthcare Industry

    01 Nov 2022

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sales-focus-inc-expands-sales-outsourcing-services-into-the-healthcare-industry-with-six-new-clients-301664530.html

    PR NEWSWIRE
    01 Nov 2022
    Share Share
    AlChem Life USA and Stevenson Advocacy LLC donate $1.35 million worth
    AlChem Life USA and Stevenson Advocacy LLC donate $1.35 million worth

    14 Oct 2021

    // PHILLYVOICE

    https://www.phillyvoice.com/alchem-life-usa-and-stevenson-advocacy-llc-donation-immunity-boosting-supplement-0599962/

    PHILLYVOICE
    14 Oct 2021
    Share Share
    AIIMS Patna confirms efficacy of AlchemLife’s Phytorelief to combat
    AIIMS Patna confirms efficacy of AlchemLife’s Phytorelief to combat

    10 Jun 2021

    // ECONOMICTIMES

    https://health.economictimes.indiatimes.com/news/pharma/aiims-patna-confirms-efficacy-of-alchemlifes-phytorelief-to-combat-moderate-cases-of-covid-19/83401825

    ECONOMICTIMES
    10 Jun 2021
    Share Share
    University Researcher Analyzes Herbal Supplement's Potential Against COVID-19
    University Researcher Analyzes Herbal Supplement's Potential Against COVID-19

    23 Feb 2021

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/university-researcher-analyzes-herbal-supplements-potential-against-covid-19-301233869.html

    PR NEWSWIRE
    23 Feb 2021
    Share Share
    Alchemlife's Phytorelief-CC being used immunity booster
    Alchemlife's Phytorelief-CC being used immunity booster

    08 Dec 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/in/news-releases/alchemlife-s-phytorelief-cc-being-used-in-eminent-indian-hospitals-as-an-immunity-booster-845237627.html

    PR NEWSWIRE
    08 Dec 2020
    Share Share

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Sponsored Ads.
    full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    Services

    Discover the service capabilities from this company

    API Manufacturing

    Discover their expertise for : API Manufacturing

    KEY SERVICES

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Alchem International Private Ltd full-view
    Extracts from Fresh & Dried Plants
    full-view

    REF. STANDARDS & IMPURITIES

    Check the ref. standards & impurities from this company

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Contact Alchem International Private Ltd and get a quotation

    Alchem International Private Ltd is a supplier offers 51 products (APIs, Excipients or Intermediates).

    Find a price of Digoxin bulk with DMF, CEP, JDMF, WC offered by Alchem International Private Ltd

    Find a price of Atropine Sulfate bulk with DMF, CEP, WC offered by Alchem International Private Ltd

    Find a price of Colchicine bulk with DMF, CEP, WC offered by Alchem International Private Ltd

    Find a price of Hyoscine Butyl Bromide bulk with CEP, JDMF, WC offered by Alchem International Private Ltd

    Find a price of Nicotine bulk with DMF, CEP, WC offered by Alchem International Private Ltd

    Find a price of Enoxolone bulk with CEP, WC offered by Alchem International Private Ltd

    Find a price of Methscopolamine Bromide bulk with DMF, WC offered by Alchem International Private Ltd

    Find a price of Scopolamine bulk with DMF, WC offered by Alchem International Private Ltd

    Find a price of Scopolamine Hydrobromide bulk with DMF, WC offered by Alchem International Private Ltd

    Find a price of Thiocolchicoside bulk with CEP, WC offered by Alchem International Private Ltd

    Find a price of 10-Deacetylbaccatin- III bulk with DMF offered by Alchem International Private Ltd

    Find a price of Benzethonium Chloride bulk with WC offered by Alchem International Private Ltd

    Find a price of Calcium Sennoside bulk with JDMF offered by Alchem International Private Ltd

    Find a price of Centella Asiatica Triterpenes bulk with WC offered by Alchem International Private Ltd

    Find a price of Cimetropium Bromide bulk with WC offered by Alchem International Private Ltd

    Find a price of Digoxin bulk with CEP offered by Alchem International Private Ltd

    Find a price of Docetaxel bulk with WC offered by Alchem International Private Ltd

    Find a price of Homatropine Methylbromide bulk with WC offered by Alchem International Private Ltd

    Find a price of Hyoscyamine Sulfate bulk with WC offered by Alchem International Private Ltd

    Find a price of Nicotine bulk with CEP offered by Alchem International Private Ltd

    Find a price of Paclitaxel bulk with WC offered by Alchem International Private Ltd

    Find a price of Quinine Hydrochloride bulk with WC offered by Alchem International Private Ltd

    Find a price of Quinine Sulfate bulk with WC offered by Alchem International Private Ltd

    Find a price of Reserpine bulk with WC offered by Alchem International Private Ltd

    Find a price of Sennosides bulk with JDMF offered by Alchem International Private Ltd

    Find a price of Vincamine bulk with WC offered by Alchem International Private Ltd

    Find a price of Vinpocetine bulk with WC offered by Alchem International Private Ltd

    Find a price of Yohimbine Hydrochloride bulk with WC offered by Alchem International Private Ltd

    Find a price of 18 Beta-Glycyrrhetinic Acid bulk offered by Alchem International Private Ltd

    Find a price of Aescin bulk offered by Alchem International Private Ltd

    Find a price of Ammonium Glycyrrhizinate bulk offered by Alchem International Private Ltd

    Find a price of Andrographolide bulk offered by Alchem International Private Ltd

    Find a price of Atropine bulk offered by Alchem International Private Ltd

    Find a price of Belladonna Leaf Extract bulk offered by Alchem International Private Ltd

    Find a price of Boswellia Serrata bulk offered by Alchem International Private Ltd

    Find a price of Cimetropium Bromide bulk offered by Alchem International Private Ltd

    Find a price of Colchicine bulk offered by Alchem International Private Ltd

    Find a price of Coleus Forskohlii Extract bulk offered by Alchem International Private Ltd

    Find a price of Dipotassium Glycyrrhizinate bulk offered by Alchem International Private Ltd

    Find a price of Glabridin bulk offered by Alchem International Private Ltd

    Find a price of Glycrrhizin bulk offered by Alchem International Private Ltd

    Find a price of Homatropine Hydrobromide bulk offered by Alchem International Private Ltd

    Find a price of Horse Chestnut Extract bulk offered by Alchem International Private Ltd

    Find a price of Hyoscine Butyl Bromide bulk offered by Alchem International Private Ltd

    Find a price of Nicotine Benzoate bulk offered by Alchem International Private Ltd

    Find a price of Nicotine Lactate bulk offered by Alchem International Private Ltd

    Find a price of Nicotine Salicylate bulk offered by Alchem International Private Ltd

    Find a price of Pygeum Extract bulk offered by Alchem International Private Ltd

    Find a price of Ruscogenin bulk offered by Alchem International Private Ltd

    Find a price of Scopine Hydrochloride bulk offered by Alchem International Private Ltd

    Find a price of Valerian Officinalis Extract bulk offered by Alchem International Private Ltd

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search